Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)
MY-CHOICE
Online Personalized and Patient-preferred Comprehensive Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)
2 other identifiers
interventional
30
1 country
3
Brief Summary
The goal of this feasibility study is to assess if the personalised online psychological intervention MY-CHOICE is acceptable to adults with ischemic heart disease and anxiety or depression. It will also examine the reasons for drop-out. The main questions the study aims to answer are: How many participants complete the intervention and what are the reasons for drop-out. And what are the pre-post change scores on anxiety and depression. Participants will: Complete the MY-CHOICE intervention consisting of 6-12 weeks with online modules on various topics based on individual needs in combination with video- or telephone calls with a therapist (psychologist or a trained master student in Psychology) on a need-to basis. Answer a set of questionnaires pre and post intervention. Participate in a brief interview post intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 4, 2025
CompletedFirst Submitted
Initial submission to the registry
March 25, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
May 6, 2026
April 1, 2026
1.2 years
March 25, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Drop-out rate
From enrollment to end of treatment i.e., from 0 to 13 weeks
Secondary Outcomes (6)
Limited efficacy on depression (HADS-D)
From baseline to completion of 3-month follow-up which is administered after 13 weeks.
Limited efficacy Anxiety (HADS-A)
From completion of baseline questionnaire to completion of post intervention questionnaire administered 13 weeks after enrollment.
Patient satisfaction with intervention
Administered in the FU-questionnaire 13 weeks after enrollment
adherence to intervention
immediately after completion of intervention. i.e. between 6 and 12 weeks depending on the length of intervention. Possibly sooner if a patient drops out.
Limited efficacy on stress
Administered in the FU-questionnaire 13 weeks after enrollment
- +1 more secondary outcomes
Study Arms (1)
Psychological intervention
EXPERIMENTALOnline psychological intervention for anxiety and depression, tailored to the patients´ individual needs. Duration 6-12 weeks. The psychological intervention is provided as add-on to treatment as usual (i.e., the patients´ individual medical treatment and rehabilitation program.)
Interventions
Online psychological treatment of anxiety and depression for patients with ischemic heart disease tailored to individual needs. The treatment includes access to an online treatment platform offering psychological content and written communication with the therapist and telephone-video conversations with the therapist. The intervention is tailored to meet the patients´ individual needs.
Eligibility Criteria
You may qualify if:
- ischemic heart disease (diagnostic codes I20-I25),
- referred for CR with a positive screen for depression and/or anxiety with the Hospital Anxiety and Depression Scale (HADS ≥ 8)
- access to and ability to use a computer or tablet
- proficient in the Danish language
You may not qualify if:
- Severe psychiatric disorder (i.e., borderline disorder, schizophrenia or bipolar disorder) that requires psychiatric care
- severe cognitive difficulties (e.g., severe brain damage, mental retardation, or dementia) that will prevent patients from participating
- endorsement of suicidal ideation with suicidal thoughts (purpose designed questions) that cannot be handled in the intervention
- participation in other intervention studies focused (unless they are clinical studies)
- seeing a psychologist or mental health professional for the treatment of anxiety and depression
- not being able or willing to spend 3-4 hours on the intervention each week
- experiencing significant life stressors that hinder adherence to the MY-CHOICE treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Aarhus University Hospital Skejbycollaborator
- Aalborg University Hospitalcollaborator
- Zealand University Hospitalcollaborator
Study Sites (3)
Aalborg University Hospital, Department of Cardiology
Aalborg, 9000, Denmark
Aarhus University Hospital, Department of Cardiology
Aarhus, 8200, Denmark
Zealand University Hospital, Roskilde, Department of Cardiology
Roskilde, 4000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2026
First Posted
May 6, 2026
Study Start
July 4, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share